ZA928607B - Compositions and methods for preventing adhesion formulation. - Google Patents
Compositions and methods for preventing adhesion formulation.Info
- Publication number
- ZA928607B ZA928607B ZA928607A ZA928607A ZA928607B ZA 928607 B ZA928607 B ZA 928607B ZA 928607 A ZA928607 A ZA 928607A ZA 928607 A ZA928607 A ZA 928607A ZA 928607 B ZA928607 B ZA 928607B
- Authority
- ZA
- South Africa
- Prior art keywords
- rgd
- compositions
- methods
- peptide
- preventing adhesion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78923191A | 1991-11-07 | 1991-11-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA928607B true ZA928607B (en) | 1993-06-07 |
Family
ID=25146991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA928607A ZA928607B (en) | 1991-11-07 | 1992-11-09 | Compositions and methods for preventing adhesion formulation. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5629294A (xx) |
EP (1) | EP0667783B1 (xx) |
AT (1) | ATE179074T1 (xx) |
AU (1) | AU3064892A (xx) |
DE (1) | DE69229004D1 (xx) |
TW (1) | TW269634B (xx) |
WO (1) | WO1993008818A1 (xx) |
ZA (1) | ZA928607B (xx) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5981719A (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US6090925A (en) | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
DE19529909C2 (de) * | 1995-08-15 | 1998-04-09 | Fresenius Ag | Wässrige Spüllösung |
EP0793965A3 (en) * | 1996-02-29 | 1999-02-24 | Tano, Yasuo | Prophylactic/therapeutic composition for secondary cataract |
JP4234803B2 (ja) | 1997-10-27 | 2009-03-04 | 久光製薬株式会社 | 薬物放出速度が制御された医薬組成物 |
WO2000004941A1 (en) * | 1998-07-24 | 2000-02-03 | Pharmacal Biotechnologies, Inc. | Osseous tissue reconstruction system and method |
US6730775B1 (en) | 1999-03-23 | 2004-05-04 | University Of Southern California | Methods for limiting scar and adhesion formation |
US6312725B1 (en) | 1999-04-16 | 2001-11-06 | Cohesion Technologies, Inc. | Rapid gelling biocompatible polymer composition |
JP2003500171A (ja) * | 1999-06-01 | 2003-01-07 | ブリストル−マイヤーズ スクイブ カンパニー | より炎症性応答の少ないフィブリンシーラントおよびこれを用いる方法 |
US20010053766A1 (en) * | 2000-02-11 | 2001-12-20 | Janardan Kumar | Method of treating disorders of the eye |
EP1875924B1 (en) * | 2003-03-28 | 2010-04-28 | FUJIFILM Manufacturing Europe B.V. | RGD-enriched gelatine-like proteins for prevention of platelet aggregation |
EP1722780A4 (en) * | 2003-11-26 | 2008-12-17 | Univ Duke | METHOD FOR PREVENTING OR TREATING GLAUCOMA |
WO2006083260A2 (en) | 2004-04-28 | 2006-08-10 | Angiotech Biomaterials Corporation | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
US9101581B2 (en) | 2008-10-27 | 2015-08-11 | Eyegene Inc. | Method for treating vascular-related disease |
CN101379082A (zh) | 2006-01-19 | 2009-03-04 | 爱吉恩公司 | 治疗血管相关疾病的包含肽的药物组合物 |
WO2007083949A1 (en) * | 2006-01-19 | 2007-07-26 | Eyegene Inc. | Pharmaceutical composition for treating vascular-related diseases comprising peptide |
AU2008297935A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a RGD-peptide and/or parathyroid hormone (1-34 ) as anti-HIV agent |
CA2698852A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
AU2008297899A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of human neuropeptide as a therapeutic agent |
AU2008297905A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a laminin peptide as a therapeutic agent |
US20110250284A1 (en) * | 2008-06-24 | 2011-10-13 | Lavik Erin B | Nanoparticles for Use as Synthetic Platelets and Therapeutic Agent Delivery Vehicles |
US9555071B2 (en) * | 2012-06-13 | 2017-01-31 | Thien Nguyen | Methods and compositions for the treatment of axonal and neuronal degeneration |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4792525A (en) * | 1982-08-04 | 1988-12-20 | La Jolla Cancer Research Foundation | Tetrapeptide |
US4517686A (en) * | 1982-08-04 | 1985-05-21 | La Jolla Cancer Research Foundation | Polypeptide |
US4614517A (en) * | 1982-08-04 | 1986-09-30 | La Jolla Cancer Research Foundation | Tetrapeptide |
US4661111A (en) * | 1982-08-04 | 1987-04-28 | La Jolla Cancer Research Foundation | Polypeptide |
US4578079A (en) * | 1982-08-04 | 1986-03-25 | La Jolla Cancer Research Foundation | Tetrapeptide |
US4589881A (en) * | 1982-08-04 | 1986-05-20 | La Jolla Cancer Research Foundation | Polypeptide |
US4746508A (en) * | 1983-06-06 | 1988-05-24 | Beth Israel Hospital Assn. | Drug administration |
US5352664A (en) * | 1986-10-31 | 1994-10-04 | Board Of Regents, The University Of Texas System | Thrombin derived polypeptides; compositions and methods for use |
ES2052595T3 (es) * | 1986-12-15 | 1994-07-16 | Inst Nat Sante Rech Med | Nuevos derivados peptidicos y su aplicacion en especial en terapeutica. |
US4857508A (en) * | 1987-12-03 | 1989-08-15 | Monsanto Company | Novel platelet-aggregation inhibitor peptide derivatives |
JPH02240020A (ja) * | 1989-01-26 | 1990-09-25 | Childrens Medical Center Corp:The | 外科的切除後の腫瘍再発阻止剤 |
NZ235563A (en) * | 1989-10-13 | 1993-04-28 | Merck & Co Inc | Fibrinogen receptor antagonist and pharmaceutical composition |
NZ235564A (en) * | 1989-10-13 | 1993-10-26 | Merck & Co Inc | Fibrinogen receptor antagonist and pharmaceutical compositions |
US5169833A (en) * | 1989-12-15 | 1992-12-08 | G. D. Searle & Co. | Substituted cyclic pentapeptides |
-
1992
- 1992-11-06 EP EP92924282A patent/EP0667783B1/en not_active Expired - Lifetime
- 1992-11-06 AU AU30648/92A patent/AU3064892A/en not_active Abandoned
- 1992-11-06 AT AT92924282T patent/ATE179074T1/de not_active IP Right Cessation
- 1992-11-06 DE DE69229004T patent/DE69229004D1/de not_active Expired - Lifetime
- 1992-11-06 WO PCT/US1992/009494 patent/WO1993008818A1/en active IP Right Grant
- 1992-11-09 ZA ZA928607A patent/ZA928607B/xx unknown
- 1992-11-17 TW TW081109192A patent/TW269634B/zh active
-
1994
- 1994-01-06 US US08/178,482 patent/US5629294A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE179074T1 (de) | 1999-05-15 |
DE69229004D1 (de) | 1999-05-27 |
US5629294A (en) | 1997-05-13 |
EP0667783A1 (en) | 1995-08-23 |
TW269634B (xx) | 1996-02-01 |
EP0667783B1 (en) | 1999-04-21 |
WO1993008818A1 (en) | 1993-05-13 |
AU3064892A (en) | 1993-06-07 |
EP0667783A4 (en) | 1995-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW269634B (xx) | ||
US4474753A (en) | Topical drug delivery system utilizing thermosetting gels | |
FI970522A (fi) | Koostumukset ja menetelmät pidennetyn paikallisanestesian aikaansaamiseksi | |
CA2203033A1 (en) | Compounds and compositions for delivering active agents | |
CA2271750A1 (en) | Prolonged anesthesia in joints and body spaces | |
CA2186126A1 (en) | Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix | |
FI945912A0 (fi) | Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö | |
DK0600079T3 (da) | Oral 1alpha-hydroxyprævitamin D | |
ES2158611T3 (es) | Composicion en gel inyectable con efecto retard y procedimiento para la preparacion de dicha composicion. | |
GB9316895D0 (en) | Hepatoselective insulin analogues | |
GR3036798T3 (en) | Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules | |
ATE167800T1 (de) | Polymeres arzneimittelabgabesystem | |
NZ333724A (en) | Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions | |
NO305581B1 (no) | Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose | |
TW228474B (xx) | ||
IE61346B1 (en) | A permeable material to fit around the teeth or gums of a mammal | |
ZA898667B (en) | Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment | |
CA2202397A1 (en) | Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders | |
CA2156481A1 (en) | 5-ht2 receptor antagonist compositions useful in treating venous conditions | |
ATE136773T1 (de) | Kollagenmikrokapseln enthaltende injezierbare zusammensetzung | |
ATE289506T1 (de) | Hemmung der tnf-aktivität mit zusammensetzungen enthaltend heparin und lösliche tnf rezeptoren | |
Nawata et al. | Bone Regeneration in Femoral Defect Filled with Fibrin Sealant. An Experimental Study | |
CA2300806A1 (en) | Dexamethasone gel | |
MX9709904A (es) | Formulaciones de hidroxiapatita biocompatibles y usos de las mismas. |